Status:
COMPLETED
Personalized Medicine in Patients With Infective Endocarditis
Lead Sponsor:
Fundación para la Investigación Biosanitaria del Principado de Asturias
Conditions:
Infective Endocarditis
Response, Acute Phase
Eligibility:
All Genders
18+ years
Brief Summary
The hypothesis underlying this work is the identification of different sub phenotypes of patients with infective endocarditis through the study of the host's response to infection. Furthemore, metage...
Detailed Description
Infective endocarditis is a life-threatening infection of heart valves and adjacent structures characterized by vegetations on valves and other endocardial surfaces, with tissue destruction and risk o...
Eligibility Criteria
Inclusion
- Diagnosis of active infective endocarditis according to the modified Duke criteria.
Exclusion
- Pregnancy
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04838938
Start Date
March 1 2021
End Date
July 1 2023
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain, 33011